Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$71.58 - $87.29 $86,826 - $105,882
-1,213 Reduced 20.24%
4,780 $350 Million
Q4 2023

Feb 05, 2024

SELL
$73.27 - $83.09 $95,251 - $108,017
-1,300 Reduced 17.83%
5,993 $485 Million
Q3 2023

Nov 07, 2023

SELL
$73.94 - $80.67 $14,788 - $16,134
-200 Reduced 2.67%
7,293 $547 Million
Q2 2023

Aug 04, 2023

SELL
$76.01 - $86.7 $1,900 - $2,167
-25 Reduced 0.33%
7,493 $575 Million
Q1 2023

May 03, 2023

SELL
$77.31 - $88.08 $773 - $880
-10 Reduced 0.13%
7,518 $624 Million
Q4 2022

Feb 03, 2023

BUY
$62.32 - $89.47 $81,016 - $116,311
1,300 Added 20.87%
7,528 $646 Million
Q3 2022

Nov 03, 2022

BUY
$59.54 - $68.01 $11,908 - $13,602
200 Added 3.32%
6,228 $384 Million
Q2 2022

Aug 03, 2022

BUY
$57.72 - $65.01 $18,585 - $20,933
322 Added 5.64%
6,028 $372,000
Q1 2022

Apr 29, 2022

SELL
$57.92 - $72.58 $191,136 - $239,514
-3,300 Reduced 36.64%
5,706 $339,000
Q4 2021

Feb 16, 2022

BUY
$64.88 - $73.64 $4,217 - $4,786
65 Added 0.73%
9,006 $653,000
Q3 2021

Nov 05, 2021

BUY
$67.69 - $73.03 $54,152 - $58,424
800 Added 9.83%
8,941 $624,000
Q2 2021

Aug 10, 2021

BUY
$63.47 - $69.35 $6,347 - $6,934
100 Added 1.24%
8,141 $560,000
Q1 2021

May 03, 2021

BUY
$60.0 - $68.46 $222,000 - $253,301
3,700 Added 85.23%
8,041 $519,000
Q4 2020

Feb 05, 2021

BUY
$56.65 - $64.55 $22,660 - $25,820
400 Added 10.15%
4,341 $252,000
Q3 2020

Nov 06, 2020

SELL
$62.1 - $78.08 $21,735 - $27,328
-350 Reduced 8.16%
3,941 $249,000
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $53,169 - $61,740
-735 Reduced 14.62%
4,291 $330,000
Q1 2020

May 07, 2020

BUY
$62.63 - $80.22 $45,093 - $57,758
720 Added 16.72%
5,026 $375,000
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $10,167 - $11,183
-165 Reduced 3.69%
4,306 $279,000
Q3 2019

Nov 08, 2019

BUY
$62.51 - $69.0 $37,193 - $41,055
595 Added 15.35%
4,471 $283,000
Q2 2019

Aug 07, 2019

SELL
$61.87 - $69.38 $25,985 - $29,139
-420 Reduced 9.78%
3,876 $0
Q1 2019

May 07, 2019

SELL
$62.53 - $70.05 $188,590 - $211,270
-3,016 Reduced 41.25%
4,296 $0
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $16,043 - $20,935
-265 Reduced 3.5%
7,312 $457,000
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $50,965 - $56,427
-715 Reduced 8.62%
7,577 $0
Q2 2018

Aug 06, 2018

SELL
$64.88 - $75.68 $47,816 - $55,776
-737 Reduced 8.16%
8,292 $0
Q1 2018

May 08, 2018

BUY
$72.84 - $88.8 $3,277 - $3,996
45 Added 0.5%
9,029 $0
Q4 2017

Feb 05, 2018

SELL
$71.15 - $83.52 $88,937 - $104,400
-1,250 Reduced 12.21%
8,984 $0
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $737,973 - $874,699
10,234
10,234 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Adell Harriman & Carpenter Inc Portfolio

Follow Adell Harriman & Carpenter Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.